In lung cancer, high AURK expression predicts poor prognosis38,39 (Fig. 2c, d; Supplementary Fig. 6), and can enhance activation of EGFR/RAS effectors including AKT, ERK1/2, and EMT-associated proteins, promoting drug resistance and tumor invasion40–43. This evidence concerns the gene MAPK3 and neoplasm.